Exclusivity Patents and exclusivity Drug Information Prescribing and other information DMFs Type 2 master files Databases Free access to database search 21 CFR FDA regulations for this API Federal Register FR search results for this API Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… Nefazodone Hydrochloride Tablets, 50, 100, 150, 200 & 250 mg, Ranbaxy ANDA 76-409 9/16/03 Nefazodone Hydrochloride Tablets, 50, 100, 150, 200 & 250 mg, Ranbaxy ANDA 76-409 4/17/03 Nefazodone Hydrochloride Tablets, 50, 100, 150, 200 & 250 mg, Dr. Reddy's ANDA 76-309 9/16/03 Nefazodone Hydrochloride Tablets, 50, 100, 150, 200 & 250 mg, Dr. Reddy's ANDA 76-309 7/7/03 Nefazodone Hydrochloride Tablets, 50, 100, 150, 200 & 250 mg, Eon Labs, ANDA 76-302 9/16/03 Nefazodone Hydrochloride Tablets, 50, 100, 150, 200 & 250 mg, Eon Labs, ANDA 76-302 10/28/02 Nefazodone Hydrochloride Tablets, 50, 100, 150, 200 & 250 mg, Roxane, ANDA 76-196 9/16/03 Nefazodone Hydrochloride Tablets, 50, 100, 150, 200 & 250 mg, Roxane, ANDA 76-196 1/14/03 Nefazodone Hydrochloride Tablets, 100, 150, 200 & 250 mg, Mylan ANDA 76-129 9/16/03 Nefazodone Hydrochloride Tablets, 100, 150, 200 & 250 mg, Mylan ANDA 76-129 10/29/02 Nefazodone Hydrochloride Tablets, 150, 200 & 250 mg, Watson, ANDA 76-073 9/16/03 Nefazodone Hydrochloride Tablets, 100, 150, 200 & 250 mg, Watson, ANDA 76-073 10/29/02 Nefazodone Hydrochloride Tablets, 50, 100, 150, 200 & 250 mg, Geneva ANDA 76-072 9/16/03 Nefazodone Hydrochloride Tablets, 50, 100, 150, 200 & 250 mg, Geneva ANDA 76-072 1/30/03 Nefazodone Hydrochloride Tablets, 50, 100, 150, 200 & 250 mg, Teva ANDA 76-037 9/16/03 Nefazodone Hydrochloride Tablets, 50, 100, 150, 200 & 250 mg, Ivax ANDA 75-763 9/16/03 Nefazodone Hydrochloride Tablets, 50, 100, 150, 200 & 250 mg, Ivax ANDA 75-763 Serzone (nefazodone hydrochloride) Tablets, 50, 100, 150, 200 & 250, Bristol-Myers Squibb Company NDA 20-152/S33 6/20/02 6/24/02 Serzone (nefazodone hydrochloride) Tablets, 50, 100, 150, 200 & 250, Bristol-Myers Squibb Company NDA 20-152/S31 5/5/03 7/9/03 Serzone (nefazodone hydrochloride) Tablets, 50 mg, 100 mg, 150 mg, 200 mg, and 250 mg, Bristol-Myers Squibb Company NDA 20-152/S-029 1/8/02 2/8/02 Serzone (nefazodone hydrochloride) Tablets, 50 mg, 100 mg, 150 mg, 200 mg, and 250 mg, Bristol-Myers Squibb Company NDA 20-152/S-026 3/21/01 5/1/01 Serzone (nefazodone hydrochloride) Tablets, 50 mg, 100 mg, 150 mg, 200 mg, and 250 mg, Bristol-Myers Squibb Company NDA 20-152/S-028 12/4/01 2/12/02 Serzone/Nefazodone HCl Tablets Bristol-Myers Squibb NDA 20152/S011 Serzone (nefazodone hydrochloride) Tablets, Bristol-Myers Squibb | Serzone (nefazodone hydrochloride) Tablets, Bristol-Myers Squibb, Labeling Revision Check the most up-to-date list of FDA Approvals.   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | FindingHealthOnline © 2008 Betterchem Corp.